Sophie Auriacombe

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases

Hélène-Marie Lanoiselée, Gaël Nicolas, David Wallon et al. · PLoS Medicine · 2017 · 583 citations · Full text

Risk profiles for mild cognitive impairment and progression to dementia are gender specific

Sylvaine Artéro, Marie‐Laure Ancelin, Florence Portet et al. · Journal of Neurology Neurosurgery & Psychiatry · 2008 · 273 citations

Cognitive function in primary progressive and transitional progressive multiple sclerosis: A controlled study with MRI correlates

S. J. Camp, V L Stevenson, Alan J. Thompson et al. · Brain · 1999 · 235 citations · Full text

Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk

Cécilia Samieri, Catherine Féart, Luc Letenneur et al. · American Journal of Clinical Nutrition · 2008 · 185 citations · Full text

Alzheimer's Disease, Psychiatry, Depressive Symptomatology +10

Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease who Failed to Benefit from Treatment with Donepezil

Sophie Auriacombe, J.-J. Péré, Y. Loria-Kanza et al. · Current Medical Research and Opinion · 2002 · 116 citations